Original studyMechanism of the suppression of repetitive atrial firing by isoproterenol — comparison with disopyramide
References (24)
- et al.
Atrial flutter. I. Electrophysiologic substrates and modes of initiation and termination
Am J Cardiol
(1980) - et al.
Onset of induced atrial flutter in the canine pericarditis model
J Am Coll Cardiol
(1991) - et al.
Natural and evoked atrial flutter due to circus movement in dogs. Role of abnormal atrial pathways, slow conduction, nonuniform refractory period distribution and premature beats
Am J Cardiol
(1980) - et al.
Effects of beta-adrenergic stimulation on atrial latency and atrial vulnerability in patients with paroxysmal supraventricular tachycardia
Am J Cardiol
(1988) - et al.
Relation between the widening of the fragmented atrial activity zone and atrial fibrillation
Am J Cardiol
(1983) - et al.
Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry
Am J Cardiol
(1983) - et al.
Electrophysiological evaluation of disopyramide in man
Am Heart J
(1973) - et al.
Effect of disopyramide on initiation of atrial fibrillation and relation to effective refractory period
Am J Cardiol
(1989) - et al.
Atrial conduction: effects of extrastimulus with and without atrial dysrhythmias
Am J Cardiol
(1984) - et al.
Effects of cycle lengths on atrial vulnerability
Circulation
(1977)
Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation
PACE
(1992)
Diagnostic implications of atrial vulnerability
PACE
(1979)
Cited by (13)
Mechanisms of termination and prevention of atrial fibrillation by drug therapy
2011, Pharmacology and TherapeuticsCitation Excerpt :AF vulnerability or incidence were consistently increased, but effects on other electrophysiological parameters were variable (Table 1). For example, in patients, isoprenaline caused a marked increase in conduction velocity and a small decrease in ERP, thus increasing wavelength (Shimizu et al., 1994), whereas in dogs, isoprenaline had no effect on wavelength (Rensma et al., 1988). Furthermore, adrenaline prolonged ERP in rabbit atria in-vitro (Smeets et al., 1986), whilst isoprenaline had no effect on ERP in human atrial isolated cells (Redpath et al., 2006).
Interrelationships between the autonomic nervous system and atrial fibrillation
2005, Progress in Cardiovascular DiseasesEffect of low-dose isoproterenol infusion on left atrial appendage function soon after cardioversion of chronic atrial tachyarrhythmias
2002, International Journal of CardiologyElectrophysiologic characteristics of human atrial muscle in paroxysmal atrial fibrillation
1996, American Heart JournalCardiac adrenergic control and atrial fibrillation
2010, Naunyn-Schmiedeberg's Archives of Pharmacology
Copyright © 1994 Published by Elsevier Ireland Ltd.